This inventor holds 1 USPTO granted patent. Top assignee: National Health Research Institutes. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Innovations of Yun-chang Chen
Introduction
Yun-chang Chen is a notable inventor based in Miaoli County, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific receptors involved in vascular growth.
Latest Patents
One of his key patents is focused on dual-function antibodies targeting vascular endothelial growth factor receptors 2 and 3 (VEGFR2 and VEGFR3). This patent describes an isolated antibody that includes heavy chain complementary determining regions CDR1, CDR2, and CDR3 from a heavy chain variable region sequence, as well as light chain complementary determining regions CDR1, CDR2, and CDR3 from a light chain variable region sequence. The antibody is designed to bind specifically to both VEGFR2 and VEGFR3, which are crucial in various physiological processes.
Career Highlights
Yun-chang Chen is affiliated with the National Health Research Institutes, where he conducts research and development in the field of health and medicine. His work has led to advancements in therapeutic strategies targeting vascular growth factors, which are essential in treating various diseases.
Collaborations
He has collaborated with esteemed colleagues such as Neng-Yao Shih and Ko-Jiunn Liu, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Yun-chang Chen's work exemplifies the impact of innovative research in biotechnology. His contributions, particularly in the development of targeted antibodies, highlight the importance of scientific advancements in improving health outcomes.